<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Type 2 Diabetes Clinical Reference</title>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css">
    <style>
        :root {
            --primary: #2c3e50;
            --secondary: #3498db;
            --accent: #e74c3c;
            --light: #ecf0f1;
            --dark: #34495e;
            --success: #27ae60;
            --warning: #f39c12;
            --info: #16a085;
        }
        
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
            font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
        }
        
        body {
            background-color: #f5f7fa;
            color: var(--dark);
            line-height: 1.6;
        }
        
        .container {
            max-width: 1200px;
            margin: 0 auto;
            padding: 20px;
        }
        
        header {
            background: linear-gradient(135deg, var(--primary), var(--secondary));
            color: white;
            padding: 30px 0;
            text-align: center;
            border-radius: 10px;
            margin-bottom: 30px;
            box-shadow: 0 4px 15px rgba(0, 0, 0, 0.1);
        }
        
        header h1 {
            font-size: 2.5rem;
            margin-bottom: 10px;
        }
        
        header p {
            font-size: 1.2rem;
            opacity: 0.9;
        }
        
        .card-container {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(300px, 1fr));
            gap: 25px;
            margin-bottom: 30px;
        }
        
        .card {
            background: white;
            border-radius: 10px;
            padding: 25px;
            box-shadow: 0 5px 15px rgba(0, 0, 0, 0.05);
            transition: transform 0.3s ease, box-shadow 0.3s ease;
            border-top: 4px solid var(--secondary);
        }
        
        .card:hover {
            transform: translateY(-5px);
            box-shadow: 0 8px 25px rgba(0, 0, 0, 0.1);
        }
        
        .card h2 {
            color: var(--primary);
            margin-bottom: 15px;
            font-size: 1.5rem;
            display: flex;
            align-items: center;
        }
        
        .card h2 i {
            margin-right: 10px;
            color: var(--secondary);
        }
        
        .card ul {
            list-style-type: none;
            padding-left: 20px;
        }
        
        .card ul li {
            margin-bottom: 10px;
            position: relative;
            padding-left: 25px;
        }
        
        .card ul li:before {
            content: "\f00c";
            font-family: "Font Awesome 5 Free";
            font-weight: 900;
            position: absolute;
            left: 0;
            color: var(--success);
        }
        
        .algorithm {
            background: white;
            border-radius: 10px;
            padding: 30px;
            margin-bottom: 30px;
            box-shadow: 0 5px 15px rgba(0, 0, 0, 0.05);
        }
        
        .algorithm h2 {
            color: var(--primary);
            margin-bottom: 25px;
            font-size: 1.8rem;
            text-align: center;
        }
        
        .flowchart {
            display: flex;
            flex-direction: column;
            align-items: center;
            gap: 20px;
        }
        
        .step {
            background: var(--light);
            border-radius: 8px;
            padding: 15px 25px;
            width: 100%;
            max-width: 800px;
            text-align: center;
            position: relative;
        }
        
        .step.primary {
            background: var(--secondary);
            color: white;
            font-weight: bold;
        }
        
        .step.secondary {
            background: var(--info);
            color: white;
        }
        
        .step.tertiary {
            background: var(--warning);
            color: white;
        }
        
        .step.final {
            background: var(--accent);
            color: white;
        }
        
        .arrow {
            height: 30px;
            display: flex;
            align-items: center;
            justify-content: center;
            color: var(--secondary);
            font-size: 1.5rem;
        }
        
        .monitoring {
            background: white;
            border-radius: 10px;
            padding: 30px;
            margin-bottom: 30px;
            box-shadow: 0 5px 15px rgba(0, 0, 0, 0.05);
        }
        
        .monitoring h2 {
            color: var(--primary);
            margin-bottom: 20px;
            font-size: 1.8rem;
            text-align: center;
        }
        
        .monitoring-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
            gap: 20px;
        }
        
        .monitoring-item {
            background: var(--light);
            border-radius: 8px;
            padding: 15px;
            display: flex;
            align-items: center;
        }
        
        .monitoring-item i {
            font-size: 2rem;
            color: var(--secondary);
            margin-right: 15px;
        }
        
        .red-flags {
            background: white;
            border-radius: 10px;
            padding: 30px;
            margin-bottom: 30px;
            box-shadow: 0 5px 15px rgba(0, 0, 0, 0.05);
            border-left: 5px solid var(--accent);
        }
        
        .red-flags h2 {
            color: var(--accent);
            margin-bottom: 20px;
            font-size: 1.8rem;
            text-align: center;
        }
        
        .red-flags ul {
            list-style-type: none;
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(300px, 1fr));
            gap: 15px;
        }
        
        .red-flags ul li {
            background: #fdf2f2;
            padding: 15px;
            border-radius: 8px;
            border-left: 3px solid var(--accent);
            position: relative;
            padding-left: 45px;
        }
        
        .red-flags ul li:before {
            content: "\f06a";
            font-family: "Font Awesome 5 Free";
            font-weight: 900;
            position: absolute;
            left: 15px;
            color: var(--accent);
        }
        
        footer {
            background: var(--primary);
            color: white;
            text-align: center;
            padding: 20px;
            border-radius: 10px;
            margin-top: 30px;
        }
        
        @media (max-width: 768px) {
            header h1 {
                font-size: 2rem;
            }
            
            .card-container {
                grid-template-columns: 1fr;
            }
            
            .step {
                padding: 12px 15px;
                font-size: 0.9rem;
            }
        }
    </style>
</head>
<body>
    <div class="container">
        <header>
            <h1>Type 2 Diabetes Clinical Reference</h1>
            <p>Fast decision-making algorithm for busy clinicians</p>
        </header>
        
        <div class="card-container">
            <div class="card">
                <h2><i class="fas fa-stethoscope"></i> Diagnosis & Initial Assessment</h2>
                <ul>
                    <li>Diagnostic criteria: HbA1c ≥ 48 mmol/mol (6.5%) or fasting plasma glucose ≥ 7.0 mmol/L</li>
                    <li>Initial tests: HbA1c, fasting glucose, kidney/liver function, lipids, urine ACR</li>
                    <li>Risk factors: Obesity (central), inactivity, family history, ethnicity, age >40, previous GDM, hypertension, CVD</li>
                </ul>
            </div>
            
            <div class="card">
                <h2><i class="fas fa-bullseye"></i> Management Targets</h2>
                <ul>
                    <li><strong>Glycaemic control:</strong> General population HbA1c ≤ 58 mmol/mol (7.5%)</li>
                    <li><strong>Frail patients:</strong> HbA1c ≤ 75 mmol/mol (9.0%)</li>
                    <li><strong>Blood pressure:</strong> ≤140/90 mmHg</li>
                    <li><strong>Lipids:</strong> Consider statin for all patients >40 years (or with CVD)</li>
                </ul>
            </div>
        </div>
        
        <div class="algorithm">
            <h2>Treatment Algorithm</h2>
            <div class="flowchart">
                <div class="step primary">1st LINE: Lifestyle intervention + METFORMIN</div>
                <div class="arrow"><i class="fas fa-arrow-down"></i></div>
                <div class="step">If HbA1c not at target after 3-6 months</div>
                <div class="arrow"><i class="fas fa-arrow-down"></i></div>
                <div class="step secondary">2nd LINE: Add one of:<br>
                • SGLT-2 inhibitor (esp. if CVD, heart failure, or CKD)<br>
                • DPP-4 inhibitor<br>
                • Pioglitazone<br>
                • Sulfonylurea<br>
                • GLP-1 receptor agonist</div>
                <div class="arrow"><i class="fas fa-arrow-down"></i></div>
                <div class="step">If still not at target</div>
                <div class="arrow"><i class="fas fa-arrow-down"></i></div>
                <div class="step tertiary">3rd LINE: Combination of TWO drugs from above options</div>
                <div class="arrow"><i class="fas fa-arrow-down"></i></div>
                <div class="step">If still not at target</div>
                <div class="arrow"><i class="fas fa-arrow-down"></i></div>
                <div class="step final">INSULIN therapy (refer to specialist if needed)</div>
            </div>
        </div>
        
        <div class="monitoring">
            <h2>Annual Monitoring</h2>
            <div class="monitoring-grid">
                <div class="monitoring-item">
                    <i class="fas fa-tint"></i>
                    <div>
                        <strong>HbA1c</strong><br>
                        3-6 monthly until stable, then 6 monthly
                    </div>
                </div>
                <div class="monitoring-item">
                    <i class="fas fa-weight"></i>
                    <div>
                        <strong>Weight</strong><br>
                        Every consultation
                    </div>
                </div>
                <div class="monitoring-item">
                    <i class="fas fa-heartbeat"></i>
                    <div>
                        <strong>Blood pressure</strong><br>
                        Every 3-6 months
                    </div>
                </div>
                <div class="monitoring-item">
                    <i class="fas fa-shoe-prints"></i>
                    <div>
                        <strong>Foot examination</strong><br>
                        Annual risk classification
                    </div>
                </div>
                <div class="monitoring-item">
                    <i class="fas fa-eye"></i>
                    <div>
                        <strong>Retinal screening</strong><br>
                        Annual
                    </div>
                </div>
                <div class="monitoring-item">
                    <i class="fas fa-kidneys"></i>
                    <div>
                        <strong>Kidney function</strong><br>
                        Annual eGFR, urine ACR
                    </div>
                </div>
            </div>
        </div>
        
        <div class="card-container">
            <div class="card">
                <h2><i class="fas fa-user-md"></i> Special Considerations</h2>
                <ul>
                    <li><strong>Children/young people:</strong> Refer to specialist paediatric diabetes team</li>
                    <li><strong>Pregnancy/preconception:</strong> Specialist referral, avoid metformin, SGLT-2 inhibitors, ACE inhibitors/ARBs</li>
                    <li><strong>Elderly/frail:</strong> Less stringent HbA1c targets, avoid hypoglycaemia</li>
                    <li><strong>CVD/CKD:</strong> Consider SGLT-2 inhibitors regardless of HbA1c</li>
                </ul>
            </div>
        </div>
        
        <div class="red-flags">
            <h2>Red Flags requiring urgent referral</h2>
            <ul>
                <li>HHS (hyperosmolar hyperglycaemic state)</li>
                <li>Diabetic ketoacidosis (rare in T2DM but possible)</li>
                <li>Rapidly deteriorating vision</li>
                <li>Foot ulcer with signs of infection/ischaemia</li>
                <li>Severe hypoglycaemia requiring assistance</li>
            </ul>
        </div>
        
        <footer>
            <p>Based on NICE CKS Diabetes - type 2 (July 2025)</p>
            <p>Designed for fast clinical decision-making</p>
        </footer>
    </div>
</body>
</html>